Abstract: A therapeutic nanoparticle containing a cationic polypeptide and a polyanionic molecule, in which the cationic polypeptide, exerting antibacterial activity, forms electrostatic interaction with the polyanionic molecule, and the therapeutic nanoparticle has diameter of less than 50 mun. Also disclosed are a pharmaceutical composition, a treatment method, and a preparation method, all related to the therapeutic nanoparticle.

Abstract: An automated testing system includes a server device, a first testing device and first laboratory equipment. The server device includes a storage unit, and the storage unit stores laboratory equipment data. The first testing device sets a first testing parameter, reads the laboratory equipment data, generates a first control command to the server device according to the first testing parameter and the laboratory equipment data, tests a first device under test according to the first testing parameter to generate a first testing result, and stores the first testing result in the storage unit. The first device under test is placed in the first laboratory equipment. The server device controls the operation of the first laboratory equipment according to the first control command, and the server device reads the first operating state of the first laboratory equipment and stores the first operating state in the storage unit.

Abstract: A therapeutic nanoparticle containing a cationic polypeptide and a polyanionic molecule, in which the cationic polypeptide, exerting antibacterial activity, forms electrostatic interaction with the polyanionic molecule, and the therapeutic nanoparticle has a diameter of less than 50 nm. Also disclosed are a pharmaceutical composition, a treatment method, and a preparation method, all related to the therapeutic nanoparticle.

Abstract: A high capacity power transformer (1) includes a housing (3) having top and bottom ends. A top board (32) extends outwards from four sides of the top end of the housing (3). A bottom board (33) extends outwards from four sides of the bottom end of the housing (3). A frame (4) is connected between each of four sides of the top board (32) and a corresponding one of four sides of the bottom board (33). An outer wallboard (5) envelops and is fixed to each frame (4). A sound absorbing material layer (6) is mounted to an inner face of each outer wallboard (5) facing the housing (3). The sound absorbing material layers (6) are connected to each other and surround four sides of the housing (3). The outer wallboards (5) are connected to each other and surround the four sides of the housing (3).

Abstract: Disclosed are a test kit and method for sensitively and rapidly detecting Klebsiella pneumoniae serotype K1. By using immunochromatographic test, the test kit can sensitively, rapidly and specifically identify whether specimens contain Klebsiella pneumoniae serotype K1. The sensitivity of the test kit preferably attains 1.4×105 cfu/50?.